Logo image of PMCB

PHARMACYTE BIOTECH INC (PMCB) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:PMCB - US71715X2036 - Common Stock

0.65 USD
0 (0%)
Last: 11/24/2025, 8:20:35 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to PMCB. The Buy consensus is the weighted average rating of the current analysts ratings.

PMCB was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about PMCB.
In the previous month the buy percentage consensus was at a similar level.
PMCB was analyzed by 6 analysts. More opinions would make the average more meaningful.
PMCB Historical Analyst RatingsPMCB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 1 2 3 4 5
PMCB Current Analyst RatingPMCB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2021-11-08 HC Wainwright & Co. Initiate Neutral

PHARMACYTE BIOTECH INC / PMCB FAQ

Can you provide the consensus rating for PHARMACYTE BIOTECH INC stock?

The consensus rating for PHARMACYTE BIOTECH INC (PMCB) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.